Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,500.00
Spread: 100.00 (1.852%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

AGM Trading Statement

30 Jun 2022 07:00

RNS Number : 7136Q
Camellia PLC
30 June 2022
 

30 June 2022

AGM Trading Statement

Camellia Plc (the "Company")

Camellia Plc (CAM.L) has today issued the following update on trading in the year to date.

Trading

Agriculture - Tea

Heavy monsoonal conditions across northern India and Bangladesh have resulted in reduced production. In India, the lower volumes have led to improved prices over the same period last year. In Bangladesh however, prices remain below those of the same period last year. Wage increases in West Bengal (effective 1 January 2022) have recently been agreed at 15%, substantially higher than the industry was anticipating. Wage increases for Assam remain under negotiation. Productivity improvements and other cost reduction measures are being explored in mitigation.

In Kenya, higher average prices have prevailed in the year to date but this has been partially offset by a crop volume which is lower than in the same period of last year and more in line with historic averages. Pricing levels going forward will largely depend on national production volumes. 

In Malawi, tea volumes are in line with historic averages but lower than those of 2021 and prices (as previously reported) remain under pressure.

Agriculture - nuts and fruits

Our macadamia operations continue to harvest and process their production with volumes expected to be higher than last year although as previously indicated pricing, particularly for commercial grades is under pressure.

The Hass avocado harvest has started, with early indications that volumes will be above those of last year but that pricing is likely to be under pressure in what is anticipated to be a well supplied summer market in Europe.

At Bardsley England the cherry, plum and apricot volumes appear reasonable for this coming season, with the cherry harvest already started. There are good indications for an improved apple crop later in the year. Inflation is continuing to impact profitability and integration challenges remain.

Other Agriculture

Our remaining agricultural businesses are trading well, with our arable farming operation in Brazil selling into strong markets.

Other Investments

Our non-agriculture businesses in the UK have had a difficult start to the year. AJT Engineering continues to face challenges due to supply chain delays and cost inflation. ACS&T has received notice of termination from a substantial customer, however, it has been successful in partially offsetting the revenue and profit impact following new storage customer wins.

BF&M, our 37.4% owned associate, recently issued its first quarter results for 2022 which, disappointingly, show a loss after tax for the period of Bermudian dollar 6.7 million (1st quarter 2021 - profit after tax Bermudian dollar 6.5 million). In the year ended 31 December 2021, Camellia's share of the results of BF&M contributed £6.4 million to Group profit. BF&M's Q1 2022 results were negatively impacted by investment income losses driven by rising interest rates and stock market volatility. Underwriting results were impacted by increases in reinsurance costs and there were higher than anticipated medical claims in the first quarter.

Outlook

As always, our financial results remain largely dependent on Agriculture where the majority of harvesting, and hence sales, takes place in the second half of the year. It is therefore too early to give a firm indication of the likely results for 2022 however despite an expected net positive profit impact from the factors set out above in respect of our Agriculture, Engineering and Food Service businesses, if the trading conditions experienced by BF&M in Q1 2022 continue through the remainder of the year it will lead to an overall adjusted profit before tax* for the Group which is significantly lower than market expectations.

As previously reported the Group continues its strategy to expand the Agriculture division to further diversify both by crop and location, and to dispose of non-core assets.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

* adjusted profit before tax seeks to present an indication of performance which is not impacted by exceptional items or items considered non-operational in nature and for example it excludes impairment charges, gains/losses on disposal of assets and restructuring costs.

 

Enquiries

Camellia Plc 01622 746655 

Malcolm Perkins, Chairman

Susan Walker, CFO

Panmure Gordon 020 7886 2500 

Nominated Adviser and Broker 

Emma Earl 

Erik Anderson

Maitland/AMO

PR 

William Clutterbuck 07785 292617

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSESFMUEESEIM
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.